Baiardini Ilaria, Contoli Marco, Corsico Angelo Guido, Scognamillo Carla, Ferri Fabio, Scichilone Nicola, Rogliani Paola, Di Marco Fabiano, Santus Pierachille, Braido Fulvio
Respiratory Unit for Continuity of Care, Department of Internal Medicine, University of Genova, Genoa, Italy,
Respiratory Diseases Department of Morphology, Surgery and Experimental Medicine-Università di Ferrara- Ferrara, Ferrara, Italy.
Respiration. 2021;100(4):291-297. doi: 10.1159/000513953. Epub 2021 Mar 11.
Disease awareness is a challenge in the management of chronic obstructive pulmonary disease (COPD).
The aim of this analysis was to explore the association between COPD optimal and suboptimal awareness, clinical parameters, and the following patient-reported outcomes: modified Medical Research Council (mMRC), Treatment Satisfaction Questionnaire (TSQM-9), COPD Assessment Test (CAT), Morisky Medication-Taking Adherence Scale (MMAS-4), and Brief Illness Perception Questionnaire (B-IPQ).
This post hoc analysis of the SAT study included all enrolled patients for whom awareness (Disease Awareness in COPD Questionnaire - DACQ) was assessed at baseline and 12 months. DACQ scores ≥80 were considered an indicator of an optimal awareness.
367 patients (25.8% women, median age 72 years) were included in the analysis. At enrollment, 74 patients (20.2%) had a DACQ score ≥80. Patients with suboptimal awareness, compared to those in which awareness was optimal, had higher median scores for CAT (p = 0.0001) and mMRC (p = 0.0031), a lower median TSQM-9 global score (p < 0.0001), and higher median B-IPQ score (p < 0.0001). The proportion of patients who had exacerbations during the previous year was higher in patients with suboptimal COPD awareness than in those with DACQ score ≥80 (42.8 vs. 21.4%, p = 0.0009). During the 12-month observation period, illness perception, adherence, and treatment satisfaction were found to be independent factors significantly associated with level of disease awareness.
The results of our post hoc analysis suggest that patients' awareness of their COPD disease is related to both clinical outcomes and how they perceive and manage their condition.
疾病认知是慢性阻塞性肺疾病(COPD)管理中的一项挑战。
本分析旨在探讨COPD最佳与次佳认知、临床参数以及以下患者报告结局之间的关联:改良医学研究委员会(mMRC)、治疗满意度问卷(TSQM-9)、慢性阻塞性肺疾病评估测试(CAT)、莫利斯基服药依从性量表(MMAS-4)和简短疾病感知问卷(B-IPQ)。
SAT研究的这项事后分析纳入了所有在基线和12个月时评估了认知情况(慢性阻塞性肺疾病疾病认知问卷 - DACQ)的入组患者。DACQ评分≥80被视为最佳认知指标。
367例患者(25.8%为女性,中位年龄72岁)纳入分析。入组时,74例患者(20.2%)的DACQ评分≥80。与认知最佳者相比,认知次佳的患者CAT(p = 0.0001)和mMRC(p = 0.0031)的中位评分更高,TSQM-9总体中位评分更低(p < 0.0001),B-IPQ中位评分更高(p < 0.0001)。慢性阻塞性肺疾病认知次佳的患者上一年病情加重的比例高于DACQ评分≥80的患者(42.8%对21.4%,p = 0.0009)。在12个月的观察期内,疾病感知、依从性和治疗满意度被发现是与疾病认知水平显著相关的独立因素。
我们事后分析的结果表明,患者对其慢性阻塞性肺疾病的认知与临床结局以及他们对自身病情的感知和管理方式均相关。